Cargando…

A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia

PURPOSE: Children with acute lymphoblastic leukemia (ALL) are at increased risk of vitamin D deficiency, which might make them more susceptible to developing adverse events. Previous studies showed that low vitamin D levels were associated with an increased inflammatory mucosal state and impaired mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oosterom, N., Dirks, N. F., Heil, S. G., de Jonge, R., Tissing, W. J. E., Pieters, R., van den Heuvel-Eibrink, M. M., Heijboer, A. C., Pluijm, S. M. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280960/ https://www.ncbi.nlm.nih.gov/pubmed/29922939 http://dx.doi.org/10.1007/s00520-018-4312-0

Ejemplares similares

Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2018)

Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2019)

Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia
por: Driehuis, E., et al.
Publicado: (2020)

Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia
por: Driehuis, E., et al.
Publicado: (2020)

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia
por: Oosterom, N., et al.
Publicado: (2020)

Prophylactic Treatment with Vitamins C and B2 for Methotrexate-Induced Gastrointestinal Mucositis
por: da Silva Ferreira, Ana Rita, et al.
Publicado: (2020)

Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study
por: Verwaaijen, Emma Jacobine, et al.
Publicado: (2022)

Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone
por: Warris, Lidewij T., et al.
Publicado: (2016)

Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols
por: van Atteveld, Jenneke E., et al.
Publicado: (2021)

Feeding strategies in pediatric cancer patients with gastrointestinal mucositis: a multicenter prospective observational study and international survey
por: Kuiken, Nicoline S.S., et al.
Publicado: (2017)

Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia
por: van Atteveld, Jenneke E, et al.
Publicado: (2021)

Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design
por: van Hulst, A. M., et al.
Publicado: (2021)

Vitamin D: marker, measurand & measurement
por: Dirks, Niek F, et al.
Publicado: (2023)

The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia
por: Verwaaijen, Emma J., et al.
Publicado: (2023)

Effect of minimal enteral feeding on recovery in a methotrexate-induced gastrointestinal mucositis rat model
por: Kuiken, Nicoline S. S., et al.
Publicado: (2015)

PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
por: Van Dijkhuizen, P, et al.
Publicado: (2013)

Pre-therapy fasting slows epithelial turnover and modulates the microbiota but fails to mitigate methotrexate-induced gastrointestinal mucositis
por: Wardill, H. R., et al.
Publicado: (2020)

The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine
por: Dirks, Niek F., et al.
Publicado: (2018)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, Pieter E H, et al.
Publicado: (2011)

Development of a self-limiting model of methotrexate-induced mucositis reinforces butyrate as a potential therapy
por: da Silva Ferreira, A. R., et al.
Publicado: (2021)

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis
por: Heijstek, MW, et al.
Publicado: (2008)

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2015)

Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia.
por: Pinkerton, C. R., et al.
Publicado: (1980)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, EH Pieter, et al.
Publicado: (2011)

Influence of bisphosphonates or recombinant human parathyroid hormone on in vitro sensitivity of acute lymphoblastic leukemia cells to chemotherapy
por: de Winter, Demi T.C., et al.
Publicado: (2022)

Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio
por: Gosselt, Helen R., et al.
Publicado: (2020)

Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients
por: Gosselt, Helen R., et al.
Publicado: (2021)

Biomarkers and non-invasive tests for gastrointestinal mucositis
por: Kuiken, N. S. S., et al.
Publicado: (2017)

Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis
por: Gosselt, Helen R., et al.
Publicado: (2020)

Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.
por: Pinkerton, C. R., et al.
Publicado: (1982)

Methotrexate-induced mucositis with extra-mucosal involvement after acidental overdose
por: Rampon, Greice, et al.
Publicado: (2018)

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

Risk factors for steroid‐induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review
por: van Hulst, Annelienke M., et al.
Publicado: (2021)

EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age
por: Stevens, A, et al.
Publicado: (2014)

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis
por: de Rotte, Maurits C. F. J., et al.
Publicado: (2018)

High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia
por: Jastaniah, Wasil, et al.
Publicado: (2018)

Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
por: van Hulst, Annelienke M., et al.
Publicado: (2023)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study
por: van Dijkhuizen, Evert Hendrik Pieter, et al.
Publicado: (2015)

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
por: Pearson, A. D., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_ac7b4gtf4lnstvm1j1nus9pks0